Evrofarma SA (EVROF.AT)
EUR 1.84
(0.27%)
EUR 1.84
(0.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 47.35 Million EUR | -2.98% |
| 2022 | 48.81 Million EUR | 4.93% |
| 2021 | 46.52 Million EUR | 0.31% |
| 2020 | 46.37 Million EUR | 12.56% |
| 2019 | 41.2 Million EUR | -6.85% |
| 2018 | 44.23 Million EUR | -1.92% |
| 2017 | 45.09 Million EUR | 3.07% |
| 2016 | 43.75 Million EUR | -1.34% |
| 2015 | 44.34 Million EUR | -6.18% |
| 2014 | 47.26 Million EUR | 1.41% |
| 2013 | 46.61 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 49.55 Million EUR | 0.0% |
| 2023 Q2 | 54.08 Million EUR | 0.0% |
| 2023 Q1 | 54.08 Million EUR | 10.8% |
| 2023 FY | 47.35 Million EUR | -2.98% |
| 2023 Q4 | 47.35 Million EUR | 0.0% |
| 2023 Q3 | 47.35 Million EUR | -12.44% |
| 2022 Q1 | 51.88 Million EUR | 11.52% |
| 2022 Q3 | 48.81 Million EUR | -5.91% |
| 2022 Q4 | 48.81 Million EUR | 0.0% |
| 2022 FY | 48.81 Million EUR | 4.93% |
| 2022 Q2 | 51.88 Million EUR | 0.0% |
| 2021 Q3 | 46.52 Million EUR | -4.36% |
| 2021 Q1 | 48.64 Million EUR | 4.88% |
| 2021 FY | 46.52 Million EUR | 0.31% |
| 2021 Q2 | 48.64 Million EUR | 0.0% |
| 2021 Q4 | 46.52 Million EUR | 0.0% |
| 2020 Q3 | 46.37 Million EUR | 9.31% |
| 2020 Q2 | 42.42 Million EUR | 0.0% |
| 2020 Q1 | 42.42 Million EUR | 2.97% |
| 2020 Q4 | 46.37 Million EUR | 0.0% |
| 2020 FY | 46.37 Million EUR | 12.56% |
| 2019 Q1 | 45.58 Million EUR | 3.06% |
| 2019 FY | 41.2 Million EUR | -6.85% |
| 2019 Q2 | 45.58 Million EUR | 0.0% |
| 2019 Q4 | 41.2 Million EUR | 0.0% |
| 2019 Q3 | 41.2 Million EUR | -9.62% |
| 2018 FY | 44.23 Million EUR | -1.92% |
| 2018 Q4 | 44.23 Million EUR | 0.0% |
| 2018 Q2 | 46.33 Million EUR | 0.0% |
| 2018 Q1 | 46.33 Million EUR | 2.74% |
| 2018 Q3 | 44.23 Million EUR | -4.53% |
| 2017 Q4 | 45.09 Million EUR | 0.0% |
| 2017 Q1 | 45.36 Million EUR | 3.68% |
| 2017 Q2 | 45.36 Million EUR | 0.0% |
| 2017 FY | 45.09 Million EUR | 3.07% |
| 2017 Q3 | 45.09 Million EUR | -0.59% |
| 2016 Q2 | 45.82 Million EUR | 0.0% |
| 2016 Q1 | 45.82 Million EUR | 3.34% |
| 2016 FY | 43.75 Million EUR | -1.34% |
| 2016 Q4 | 43.75 Million EUR | 0.0% |
| 2016 Q3 | 43.75 Million EUR | -4.53% |
| 2015 Q2 | 47.65 Million EUR | 2.39% |
| 2015 FY | 44.34 Million EUR | -6.18% |
| 2015 Q1 | 46.53 Million EUR | -1.55% |
| 2015 Q3 | 46.03 Million EUR | -3.39% |
| 2015 Q4 | 44.34 Million EUR | -3.67% |
| 2014 Q1 | 45.61 Million EUR | -2.14% |
| 2014 Q3 | 49.83 Million EUR | 4.5% |
| 2014 Q4 | 47.26 Million EUR | -5.15% |
| 2014 FY | 47.26 Million EUR | 1.41% |
| 2014 Q2 | 47.69 Million EUR | 4.55% |
| 2013 Q2 | 48.23 Million EUR | 1.35% |
| 2013 Q4 | 46.61 Million EUR | -5.08% |
| 2013 FY | 46.61 Million EUR | 0.0% |
| 2013 Q1 | 47.59 Million EUR | 0.0% |
| 2013 Q3 | 49.11 Million EUR | 1.81% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 55.05 Million EUR | 13.99% |
| Kri-Kri Milk Industry S.A. | 160.73 Million EUR | 70.537% |
| Loulis Food Ingredients S.A. | 204.48 Million EUR | 76.841% |